Adverum Biotechnologies Inc (ADVM)
9.79
+0.07
(+0.72%)
USD |
NASDAQ |
May 01, 16:00
9.81
+0.02
(+0.20%)
After-Hours: 20:00
Adverum Biotechnologies Shares Outstanding: 20.75M for March 21, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 21, 2024 | 20.75M |
March 08, 2024 | 20.75M |
February 29, 2024 | 20.74M |
February 07, 2024 | 20.72M |
December 31, 2023 | 10.14M |
October 31, 2023 | 10.10M |
September 30, 2023 | 10.10M |
August 04, 2023 | 10.10M |
June 30, 2023 | 10.10M |
May 05, 2023 | 10.06M |
April 12, 2023 | 10.06M |
April 01, 2023 | 10.06M |
March 31, 2023 | 10.06M |
March 17, 2023 | 10.06M |
December 31, 2022 | 10.01M |
November 04, 2022 | 9.973M |
September 30, 2022 | 9.973M |
August 05, 2022 | 9.933M |
June 30, 2022 | 9.927M |
May 06, 2022 | 9.877M |
April 13, 2022 | 9.877M |
April 01, 2022 | 9.875M |
March 31, 2022 | 9.877M |
March 18, 2022 | 9.875M |
December 31, 2021 | 9.838M |
Date | Value |
---|---|
October 29, 2021 | 9.815M |
September 30, 2021 | 9.814M |
July 30, 2021 | 9.813M |
June 30, 2021 | 9.812M |
April 29, 2021 | 9.794M |
April 14, 2021 | 9.793M |
April 01, 2021 | 9.793M |
March 31, 2021 | 9.793M |
February 22, 2021 | 9.780M |
December 31, 2020 | 9.755M |
October 30, 2020 | 9.748M |
September 30, 2020 | 9.747M |
August 18, 2020 | 9.733M |
August 03, 2020 | 8.066M |
June 30, 2020 | 8.064M |
May 22, 2020 | 8.030M |
April 27, 2020 | 7.997M |
April 15, 2020 | 7.989M |
March 31, 2020 | 7.988M |
February 28, 2020 | 7.968M |
February 14, 2020 | 7.825M |
December 31, 2019 | 6.733M |
October 31, 2019 | 6.459M |
September 30, 2019 | 6.458M |
July 31, 2019 | 6.446M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
6.378M
Minimum
May 31 2019
20.75M
Maximum
Mar 08 2024
9.986M
Average
9.814M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Karyopharm Therapeutics Inc | 115.07M |
Ardelyx Inc | 232.69M |
Minerva Neurosciences Inc | 6.993M |
Arcutis Biotherapeutics Inc | 114.97M |
4D Molecular Therapeutics Inc | 49.78M |